In the current case report psychiatric disorder was a significant symptom of chronic adrenal insufficiency. This case showed no severe clinical manifestation and cardinal symptoms of this metabolic disorder, like the Addisonian crisis. Klipel, in 1899, for the first time reported AD psychiatric manifestations defined as "Addisonian encephalopathy" (
4). Limited similar case series (n = 25) published from the 1940s to 1950s indicated a 64 - 85% correlation between AD and psychiatric diseases. Nonetheless, nowadays, this association is not widely considered (
2).
The majority of case studies of AD associated with psychiatric symptoms represented that male patients are slightly more influenced than females, and such symptomatology commonly can start before treatment and diagnosis of adrenal insufficiency. Depression, as the most common disorder, is accompanied by adrenal insufficiency, with commonly mild mood manifestations, motivation reduction, and behavior change. On the other hand, catatonia, psychosis, delirium, disorientation, and memory deficit are not commonly observed. Psychosis correlates with Addisonian crisis and severe AD symptoms, and merely nine case reports showed a correlation between a psychotic symptom and the primary clinical picture of adrenal insufficiency.
The cause of psychiatric disorders in AD has not been well addressed, and there are many theories suggested in some case reports. Hyponatremia is linked to brain swelling and encephalopathy, leading to memory, consciousness, and thinking disorders. Decreased glucocorticoid, which can be found in the brain, particularly the hippocampi, causes memory deficit and frontal circuit dysfunction with reduced processing speed, executive function, reasoning, and thinking. A reduction in cerebral glucocorticoid stimulation increases neural excitability, leading to an improvement in sensory information detection. Also, proopiomelanocortin (POMC) as an anterior pituitary hormone is produced secondary to reduced glucocorticoid. In addition, elevated endorphin levels are associated with psychosis and hallucinations (
4).
In the case of adrenal insufficiency diagnosis, each cause is associated with inadequate low cortisol generation. Serum cortisol levels are elevated in the early morning (about 6 AM) and range from 10 to 20 mcg/dL (275 to 555 nmol/L) compared to other times during the day. The low serum cortisol level (lower than 3 mcg/dL or 80 nmol/L) in the early morning suggests adrenal insufficiency. The patient is diagnosed with primary adrenal insufficiency (primary adrenal disease) when serum cortisol is inadequately low, and a simultaneous plasma ACTH level is very high, similar to the present case study.
In primary adrenal insufficiency, plasma ACTH at 8 AM is high (over 4000 pg/mL; 880 pmol/L). In patients with mineralocorticoid deficiency, besides cortisol deficiency, plasma renin level or activity should be assessed, while aldosterone concentrations are low, with elevated serum potassium and reduced serum sodium concentrations. On the contrary, in secondary or tertiary adrenal insufficiency, plasma ACTH levels are low or low normal (
Table 1). The normal level of ACTH at 8 AM ranges commonly from 20 to 52 pg/mL (4.5 to 12 pmol/L) in the two-site chemiluminescent assay (
5,
6). Previous studies have shown that AD is associated with other autoimmune diseases; thus, a medical history of coeliac disease, thyroid disease, vitiligo, or atrophic gastritis increases suspicion of another autoimmune diagnosis and the probability of another autoimmune polyendocrine syndrome (APS).
For AD treatment, hydrocortisone in two or three divided concentrations (total concentration: 10 to 12 mg/m3/day) is considered the glucocorticoid of choice to manage chronic primary adrenal insufficiency. Glucocorticoid dose relieves symptoms of glucocorticoid deficiency. Most patients with primary adrenal insufficiency finally need mineralocorticoid replacement using fludrocortisone. Dehydroepiandrosterone (DHEA) therapy is suggested for females with an impaired sense of well-being or mood instead of optimal glucocorticoid and mineralocorticoid replacement when needed. The main points investigated in this study are:
(1) Keep in mind that psychiatric disorders, such as insomnia, agitation, and depression, can be the manifestations of AD, but they may rarely be the first manifestations;
(2) Adrenal insufficiency should be considered while treating a psychiatric patient (with depression and psychosis) with no family or personal history of psychiatric illness or cases without failed medical treatment for depression;
(3) Addison disease is an autoimmune disease that can be seen with other autoimmune diseases (type 1 diabetes, autoimmune thyroiditis, celiac disease, premature menopause, Graves' disease, pernicious anemia, and Sjögren's disease).
In conclusion, we reported a rare case of psychiatric disorder as a significant symptom of chronic adrenal insufficiency. This case indicated that physicians should be informed about the neuropsychiatric symptoms of adrenal insufficiency. This should be considered while treating a psychiatric patient (with depression and psychosis) with no family or personal history of psychiatric illness or cases who failed medical treatment for depression. Psychiatric disorders have a high prevalence, and adrenal insufficiency is a rare disease; therefore, an appropriate workup is recommended in exceptional cases such as the presence of some clinical manifestations of AD.